Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKooth Plc Regulatory News (KOO)

Share Price Information for Kooth Plc (KOO)

Share Price is delayed by 15 minutes
Get Live Data
165.00    -3.00 (-1.79%)
Bid:
162.00
Ask:
168.00
Spread: 6.00 (3.704%)
Market Cap: £59.85m
KOO Live PriceLast checked at - London Stock Exchange

Intraday Kooth Plc Share Chart

Holding in Company

8 Oct 2024 18:03

RNS Number : 4350H
Kooth PLC
08 October 2024
 

8 October 2024

 

Kooth plc

("Kooth" or the "Company)

Holding in the Company

 

The Board of Kooth was informed 8 October 2024 that Root Capital Fund II Limited Partnership, trading under the name ScaleUp Capital, classified as a Person Closely Associated with Mr. Simon Philips, a Non-Executive Director of the Company, had sold 3,755,861 Ordinary Shares on 8 October 2024. ScaleUp Capital's interest is now 9,240,679 Ordinary Shares, representing 25.2% of the Company's issued share capital.

 

This transaction was undertaken on 8 October 2024 and was completed at a price of 280 pence per Ordinary Share.

 

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

 

Enquiries:

Kooth plc

investorrelations@kooth.com

Tim Barker, CEO

Sanjay Jawa, CFO

Stifel, Nominated Adviser & Sole Broker

+44 (0) 20 7710 7600

Ben Maddison, Erik Anderson, Nicholas Harland, Ben Good

FTI Consulting

kooth@fticonsulting.com

Ben Atwell, Alex Shaw

 

 

About Kooth plc:

 

Kooth (AIM:KOO) is a global leader in youth digital mental well-being. Our mission is to provide accessible and safe spaces for everyone to achieve better mental health. Our platform is clinically robust and accredited to provide a range of therapeutic support and interventions. All our services are predicated on easy access to make early intervention and prevention a reality.

Kooth is a fully safeguarded and pre-moderated community with a library of peer and professional created content, alongside access to experienced online counsellors. There are no thresholds for support and no waiting lists.

Kooth is the longest standing digital mental health provider to hold a UK-wide accreditation from the British Association of Counselling and Psychotherapy (BACP) and according to NHS England data for 2022/23 is now the largest single access provider for mental health support for under 18s.

In 2021, Kooth began executing on its international expansion strategy, with an initial focus on the US market. This focus is due to the growing recognition of the importance of improving youth mental health in this key global healthcare market, with 1-in-6 people aged 6-17 experiencing a mental health disorder each year.

For more information, please visit www.koothplc.com.

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Kooth plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Root Capital Fund II LP

City and country of registered office (if applicable)

London, United Kingdom

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

8 October 2024

6. Date on which issuer notified (DD/MM/YYYY):

8 October 2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

25.2%

N/A

25.2%

9,240,679

Position of previous notification (if

applicable)

35.5%

n/a

35.5%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00BMCZLK30

9,240,679

25.2%

SUBTOTAL 8. A

9,240,679

25.2%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

ScaleUp Capital Fund II

23.4%

N/A

23.4%

ScaleUp Capital Fund IV

1.5%

N/A

1.5%

ScaleUp Capital Ltd

0.3%

N/A

0.3%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

London, England

Date of completion

8 October 2024

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLGZMGGNRMGDZM
Date   Source Headline
19th May 20267:00 amRNS2025 Annual Report and Notice of 2026 AGM
19th May 20267:00 amRNSDirectorate Change
20th Apr 20267:00 amRNS-R2025 Impact Report Shows Soluna's Continued Growth
8th Apr 20267:00 amRNS2025 Full Year Results
19th Mar 20267:00 amRNSNotice of Full Year Results
12th Mar 20269:19 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 202610:57 amRNSTransfer of Treasury Shares & Exercise of Options
2nd Mar 20267:00 amRNSBlock Listing Six Monthly Return
11th Feb 20265:51 pmRNSAwards under LTIP and PDMR dealing
2nd Feb 202612:48 pmRNSTransfer of Treasury Shares & Exercise of Options
28th Jan 20267:00 amRNSTrading Update
22nd Jan 20267:05 amRNSHolding(s) in Company
22nd Jan 20267:00 amRNS$2.6m contract win with new US State
17th Dec 202510:02 amRNSTransfer of Treasury Shares & Exercise of Options
4th Dec 20253:26 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNS-RKooth Acquires US Telehealth Platform
11th Nov 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
10th Oct 20252:30 pmRNSHolding(s) in Company
2nd Oct 20257:00 amRNSKooth renews New Jersey contract
24th Sep 20253:55 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNSUnaudited Half Year Results
4th Sep 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
29th Aug 20257:00 amRNSBlock Listing Six Monthly Return
8th Aug 20257:00 amRNSAppointment of Joint Corporate Broker
1st Aug 20257:00 amRNSTransfer of Treasury Shares & Exercise of Options
28th Jul 20257:00 amRNSHalf Year Trading and Operational Update
1st Jul 20257:00 amRNSKooth welcomes report on California Soluna data
27th Jun 20253:51 pmRNSHolding(s) in Company
24th Jun 20251:12 pmRNSResult of 2025 Annual General Meeting
3rd Jun 20259:32 amRNSHolding(s) in Company
23rd May 20254:06 pmRNSAwards - Long Term Incentive Plan and PDMR dealing
14th May 20257:00 amRNSAnnual Financial Report
15th Apr 20257:00 amRNSFull Year Results
31st Mar 20251:00 pmRNSHolding in Company
28th Feb 20257:00 amRNSBlock Listing Six Monthly Return
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20255:53 pmRNSHolding(s) in Company
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.